OptiNose

$4.34
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (+0.23%) Today
+$0.07 (+1.64%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell OptiNose and other stocks, options, and ETFs commission-free!

About OPTN

OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA. The listed name for OPTN is OptiNose, Inc. Common Stock.

CEO
Peter Kaighn Miller
Employees
224
Headquarters
Yardley, Pennsylvania
Founded
2000
Market Cap
222.38M
Price-Earnings Ratio
Dividend Yield
Average Volume
600.56K
High Today
$4.35
Low Today
$4.15
Open Price
$4.22
Volume
280.19K
52 Week High
$10.07
52 Week Low
$3.14

Collections

OPTN Earnings

-$0.74
-$0.49
-$0.25
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 4, Pre-Market

You May Also Like